Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bmaz001 who wrote (546)	1/29/2020 3:07:07 PM
From: scaram(o)uche	of 684

Didn't know at the time of this discussion that RTB101 is also a pan-PI3K inhibitor. Have no interest, and thought that I should pop in and mention such. Took a loss and have moved on. Wrote the company asking for some (any!) information (location, regulatory jurisdiction) concerning their Parkinson's trial and/or any RTB101 trial in combo with rapalog. Got no response. mTORC1 inhibitors have great promise, given pre-clinical observations. Hope that the company can ultimately succeed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next